Addition of rituximab to chemotherapy alone as first-line therapy improves overall survival in elderly patients with mantle cell lymphoma

Robert Griffiths, Joseph Mikhael, Michelle Gleeson, Mark Danese, Martin Dreyling

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Addition of rituximab to chemotherapy alone as first-line therapy improves overall survival in elderly patients with mantle cell lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds